Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.468 USD | +7.64% | +48.21% | +48.93% |
May. 15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
May. 14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.93% | 43.73M | |
+32.93% | 50.85B | |
+1.28% | 42.82B | |
+49.17% | 42.03B | |
-4.22% | 29.55B | |
+11.09% | 26.11B | |
-21.47% | 19.13B | |
+8.79% | 13.05B | |
+27.26% | 12.16B | |
+23.47% | 12.08B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q1 2020 Earnings Call, May 14, 2020